New York, NY., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Global Tech Industries Group, Inc. (GTII), (“GTII”), a Nevada corporation, having been tasked at a recent Board of Directors meeting to explore the potential for creative partnerships in the growing cannabis-related healthcare field, is now actively seeking and pursuing such opportunities. Mr. David Reichman, CEO and Chairman of GTII, expressed confidence that this move could be in the best, long-term interest of the Company. “One of our bedrock interests has long been in the global healthcare market. We believe that cannabis, especially as it relates to pain management and other chronic diseases, presents an unprecedented opportunity for us to get involved at the foundational level with companies in need of capital and guidance. Our Medical consultant group explored and reviewed the possible application of transdermal technology for drug delivery with one potential partner and they are very excited about this opportunity. The Company has since been in discussion with them for the past several weeks and we look forward to continuing the conversation. At the same time, we are on the lookout for additional opportunities.”
Global Tech Industries Group, Inc. (GTII) is a publicly traded holding company, with subsidiaries and affiliates that hold intellectual properties and proprietary systems in the bioscience, clean tech, and global health industries, as well as interests in energy-related businesses, and restaurant services. For more information on Global Tech Industries Group, Inc., please call 212.204.7926, see our website: www.GTII-US.com
News 
Market Data 
Discover 
